Ad is loading...
AKRO
Price
$32.73
Change
+$1.53 (+4.90%)
Updated
Nov 22 closing price
108 days until earnings call
DNLI
Price
$24.69
Change
+$0.47 (+1.94%)
Updated
Nov 22 closing price
98 days until earnings call
Ad is loading...

AKRO vs DNLI

Header iconAKRO vs DNLI Comparison
Open Charts AKRO vs DNLIBanner chart's image
Akero Therapeutics
Price$32.73
Change+$1.53 (+4.90%)
Volume$824.7K
CapitalizationN/A
Denali Therapeutics
Price$24.69
Change+$0.47 (+1.94%)
Volume$830.36K
CapitalizationN/A
AKRO vs DNLI Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AKRO vs. DNLI commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and DNLI is a Hold.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (AKRO: $32.73 vs. DNLI: $24.69)
Brand notoriety: AKRO and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 140% vs. DNLI: 101%
Market capitalization -- AKRO: $2.28B vs. DNLI: $3.55B
AKRO [@Biotechnology] is valued at $2.28B. DNLI’s [@Biotechnology] market capitalization is $3.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while DNLI’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 4 bearish.
  • DNLI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than DNLI.

Price Growth

AKRO (@Biotechnology) experienced а +16.52% price change this week, while DNLI (@Biotechnology) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.24%. For the same industry, the average monthly price growth was +6.90%, and the average quarterly price growth was +13.50%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+10.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.55B) has a higher market cap than AKRO($2.29B). AKRO YTD gains are higher at: 40.171 vs. DNLI (15.051). AKRO has higher annual earnings (EBITDA): -232.85M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. AKRO (717M). AKRO has less debt than DNLI: AKRO (36.4M) vs DNLI (52.5M). AKRO (0) and DNLI (0) have equivalent revenues.
AKRODNLIAKRO / DNLI
Capitalization2.29B3.55B64%
EBITDA-232.85M-496.05M47%
Gain YTD40.17115.051267%
P/E RatioN/AN/A-
Revenue00-
Total Cash717M837M86%
Total Debt36.4M52.5M69%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKRODNLI
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSRX18.290.29
+1.61%
NYLI Fiera SMID Growth Class A
WWSYX23.340.36
+1.57%
Westwood Quality SmallCap Fund Ultra
VIMAX349.103.38
+0.98%
Vanguard Mid Cap Index Admiral
LDVCX24.210.19
+0.79%
AXS FTSE Vntr Cptl RetTrckr C
PMFRX11.680.03
+0.26%
Pioneer Multi-Asset Income R

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+4.90%
ETNB - AKRO
62%
Loosely correlated
+4.53%
BEAM - AKRO
48%
Loosely correlated
+6.23%
PLRX - AKRO
45%
Loosely correlated
+1.01%
DNLI - AKRO
45%
Loosely correlated
+1.94%
KROS - AKRO
44%
Loosely correlated
+3.86%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+1.94%
BEAM - DNLI
63%
Loosely correlated
+6.23%
ALEC - DNLI
57%
Loosely correlated
+4.79%
JANX - DNLI
55%
Loosely correlated
+8.19%
LGND - DNLI
54%
Loosely correlated
+2.27%
NTLA - DNLI
54%
Loosely correlated
+3.62%
More